Author:
Wang Yaqin,Yuan Ting,Deng Shuwen,Zhu Xiaoling,Deng Yuling,Liu Xuelian,Liu Lei,Wang Changfa
Abstract
BackgroundNon-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined the relationship between body mass index (BMI), the metabolically healthy status, and subclinical atherosclerosis in the NAFLD population.MethodsData from asymptomatic NAFLD subjects who participated in a routine health check-up examination were collected. Participants were stratified by BMI (cutoff values: 24.0–27.9 kg/m2 for overweight and ≥28.0 kg/m2 for obesity) and metabolic status, which was defined by Adult Treatment Panel III criteria. Subclinical atherosclerosis was evaluated by brachial-ankle pulse wave velocity (baPWV) in 27,738 participants and by carotid plaque in 14,323 participants.ResultsWithin each BMI strata, metabolically unhealthy subjects had a significantly higher prevalence of subclinical atherosclerosis than metabolically healthy subjects, whereas fewer differences were observed across subjects within the same metabolic category. When BMI and metabolic status were assessed together, a metabolically unhealthy status was the main contributor to the association of clinical phenotypes with the subclinical atherosclerosis burden (all p < 0.001). When BMI and metabolic abnormalities were assessed separately, the incidence of subclinical disease did not increase across BMI categories; however, it increased with an increase in the number of metabolic abnormalities (0, 1, 2 and ≥3).ConclusionA metabolically healthy status in NAFLD patients was closely correlated with subclinical atherosclerosis, beyond that of the BMI-based obesity phenotype. The application of metabolic phenotyping strategies could enable more precise classification in evaluating cardiovascular risk in NAFLD.
Funder
National Natural Science Foundation of China
Hunan Provincial Natural Science Foundation
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Food Science
Reference53 articles.
1. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health;Eslam;Lancet Gastroenterol Hepatol,2020
2. Cause pathogenesis, and treatment of nonalcoholic steatohepatitis;Diehl;N Engl J Med,2017
3. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016;Zou;J Intern Med,2020
4. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Ye;Lancet Gastroenterol Hepatol,2020
5. Global epidemiology of lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Lu;J Gastroenterol Hepatol,2020